SAN DIEGO, CA and SCOTTSDALE, AZ--(Marketwire - June 05, 2008) - Medistem Laboratories, Inc. (OTCBB: MDSM), a biotechnology company dedicated to commercialization of its universal donor stem cell population, the Endometrial Regenerative Cell (ERC), is pleased to announce publication of a collaborative project in the area of transplant immunology.